Skip to main content
editorial
. 2023 Jul 28;12(8):1826–1829. doi: 10.21037/tlcr-23-288

Figure 1.

Figure 1

Selected target therapies of the c-Met receptor. HGF, hepatocyte growth factor; PSI, plexin-semaphorin-integrin; IPT, immunoglobulin-like, plexin, transcription factors; TK, tyrosine kinase; MET, MMNG HOS transforming gene; TKI, tyrosine kinase inhibitor.